{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:14:54Z","timestamp":1758759294119,"version":"3.44.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s11655-025-4217-y","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:03:02Z","timestamp":1747180982000},"page":"953-959","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Potential of Berberine for Rheumatoid Arthritis Prevention and Treatment"],"prefix":"10.1007","volume":"31","author":[{"given":"Hao-jie","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"4217_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1056\/NEJMra2103726","volume":"388","author":"EM Gravallese","year":"2023","unstructured":"Gravallese EM, Firestein GS. Rheumatoid arthritis\u2014common origins, divergent mechanisms. N Engl J Med 2023;388:529\u2013542.","journal-title":"N Engl J Med"},{"key":"4217_CR2","first-page":"591","volume":"18","author":"A Finckh","year":"2022","unstructured":"Finckh A, Gilbert B, Hodkinson B, et al. Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol 2022;18:591\u2013602.","journal-title":"Nat Rev Rheumatol"},{"key":"4217_CR3","doi-asserted-by":"publisher","first-page":"943","DOI":"10.5246\/jcps.2024.10.068","volume":"33","author":"Q Deng","year":"2024","unstructured":"Deng Q, Peng Z, Yan W, et al. Elucidating the therapeutic mechanism of Cang Zhu and Huang Bai in rheumatoid arthritis: a comprehensive analysis integrating network pharmacology and GEO data. J Chin Pharm Sci (Chin) 2024;33:943\u2013964.","journal-title":"J Chin Pharm Sci (Chin)"},{"key":"4217_CR4","doi-asserted-by":"publisher","first-page":"152416","DOI":"10.1016\/j.semarthrit.2024.152416","volume":"65","author":"H Meng","year":"2024","unstructured":"Meng H, Lam SH, So H, et al. Incidence and risk factors of major cardiovascular events in rheumatoid arthritis and psoriatic arthritis: a population-based cohort study. Semin Arthritis Rheum 2024;65:152416.","journal-title":"Semin Arthritis Rheum"},{"key":"4217_CR5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","volume":"400","author":"N Conrad","year":"2022","unstructured":"Conrad N, Verbeke G, Molenberghs G, et al. Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet 2022;400:733\u2013743.","journal-title":"Lancet"},{"key":"4217_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2024.07.016","volume":"128","author":"AA Drosos","year":"2024","unstructured":"Drosos AA, Venetsanopoulou AA, Pelechas E, et al. Exploring cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Eur J Intern Med 2024;128:1\u20139.","journal-title":"Eur J Intern Med"},{"key":"4217_CR7","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1056\/NEJMoa2109927","volume":"386","author":"SR Ytterberg","year":"2022","unstructured":"Ytterberg SR, Bhatt DL, Mikuls TR, et al. Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis. N Engl J Med 2022;386:316\u2013326.","journal-title":"N Engl J Med"},{"key":"4217_CR8","doi-asserted-by":"publisher","first-page":"111024","DOI":"10.1016\/j.intimp.2023.111024","volume":"124","author":"J Cheng","year":"2023","unstructured":"Cheng J, Yu Y, Zong S, et al. Berberine ameliorates collagen-induced arthritis in mice by restoring macrophage polarization via AMPK\/mTORC1 pathway switching glycolytic reprogramming. Int Immunopharmacol 2023;124:111024.","journal-title":"Int Immunopharmacol"},{"key":"4217_CR9","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.7150\/thno.30787","volume":"9","author":"X Feng","year":"2019","unstructured":"Feng X, Sureda A, Jafari S, et al. Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics. Theranostics 2019;9:1923\u20131951.","journal-title":"Theranostics"},{"key":"4217_CR10","doi-asserted-by":"publisher","first-page":"112422","DOI":"10.1016\/j.intimp.2024.112422","volume":"137","author":"Z Qin","year":"2024","unstructured":"Qin Z, Tang R, Liang J, et al. Berberine, a natural alkaloid: advances in its pharmacological effects and mechanisms in the treatment of autoimmune diseases. Int Immunopharmacol 2024;137:112422.","journal-title":"Int Immunopharmacol"},{"key":"4217_CR11","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nrrheum.2014.85","volume":"10","author":"L Tong","year":"2014","unstructured":"Tong L, Thumboo J, Tan YK, et al. The eye: a window of opportunity in rheumatoid arthritis? Nat Rev Rheumatol 2014;10:552\u2013560.","journal-title":"Nat Rev Rheumatol"},{"key":"4217_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.biopha.2017.10.113","volume":"97","author":"S Mehrzadi","year":"2018","unstructured":"Mehrzadi S, Fatemi I, Esmaeilizadeh M, et al. Hepatoprotective effect of berberine against methotrexate induced liver toxicity in rats. Biomed Pharmacother 2018;97:233\u2013239.","journal-title":"Biomed Pharmacother"},{"key":"4217_CR13","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1002\/art.42549","volume":"75","author":"V Joshua","year":"2023","unstructured":"Joshua V, Loberg Haarhaus M, Hensvold A, et al. Rheumatoid arthritis-specific autoimmunity in the lung before and at the onset of disease. Arthritis Rheumatol 2023;75:1910\u20131922.","journal-title":"Arthritis Rheumatol"},{"key":"4217_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11926-020-00960-1","volume":"22","author":"TM Wilson","year":"2020","unstructured":"Wilson TM, Trent B, Kuhn KA, et al. Microbial influences of mucosal immunity in rheumatoid arthritis. Curr Rheumatol Rep 2020;22:83.","journal-title":"Curr Rheumatol Rep"},{"key":"4217_CR15","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41584-018-0070-0","volume":"14","author":"VM Holers","year":"2018","unstructured":"Holers VM, Demoruelle MK, Kuhn KA, et al. Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction. Nat Rev Rheumatol 2018;14:542\u2013557.","journal-title":"Nat Rev Rheumatol"},{"key":"4217_CR16","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41584-021-00585-3","volume":"17","author":"MM Zaiss","year":"2021","unstructured":"Zaiss MM, Joyce Wu HJ, Mauro D, et al. The gut-joint axis in rheumatoid arthritis. Nat Rev Rheumatol 2021;17:224\u2013237.","journal-title":"Nat Rev Rheumatol"},{"key":"4217_CR17","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nm.3914","volume":"21","author":"X Zhang","year":"2015","unstructured":"Zhang X, Zhang D, Jia H, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med 2015;21:895\u2013905.","journal-title":"Nat Med"},{"key":"4217_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/JLB.3MA0121-045R","volume":"110","author":"N Zhou","year":"2021","unstructured":"Zhou N, Zou F, Cheng X, et al. Porphyromonas gingivalis induces periodontitis, causes immune imbalance, and promotes rheumatoid arthritis. J Leukoc Biol 2021;110:461\u2013473.","journal-title":"J Leukoc Biol"},{"key":"4217_CR19","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.scib.2021.12.021","volume":"67","author":"M Wang","year":"2022","unstructured":"Wang M, Liu Y, Zhao L, et al. Modulating gut microbiota in autoimmune diseases: a cutting-edge strategy from prophylaxis to therapeutics. Sci Bull (Chin) 2022;67:771\u2013773.","journal-title":"Sci Bull (Chin)"},{"key":"4217_CR20","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.coph.2013.02.008","volume":"13","author":"DL Simmons","year":"2013","unstructured":"Simmons DL. Targeting kinases: a new approach to treating inflammatory rheumatic diseases. Curr Opin Pharmacol 2013;13:426\u2013434.","journal-title":"Curr Opin Pharmacol"},{"key":"4217_CR21","doi-asserted-by":"publisher","first-page":"f1939","DOI":"10.1136\/bmj.f1939","volume":"346","author":"P Raaschou","year":"2013","unstructured":"Raaschou P, Simard JF, Holmqvist M, et al. Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden. BMJ 2013;346:f1939.","journal-title":"BMJ"},{"key":"4217_CR22","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1136\/annrheumdis-2013-204807","volume":"74","author":"Q Lv","year":"2015","unstructured":"Lv Q, Zhang W, Shi Q, et al. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial. Ann Rheum Dis 2015;74:1078\u20131086.","journal-title":"Ann Rheum Dis"},{"key":"4217_CR23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.phymed.2018.12.030","volume":"57","author":"R Huang","year":"2019","unstructured":"Huang R, Pan H, Wu J, et al. Comparison of combination therapy with methotrexate and sinomenine or leflunomide for active rheumatoid arthritis: a randomized controlled clinical trial. Phytomedicine 2019;57:403\u2013410.","journal-title":"Phytomedicine"},{"key":"4217_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10067-017-3770-y","volume":"37","author":"Z Feng","year":"2018","unstructured":"Feng Z, Xu J, He G, et al. A systemic review and meta-analysis of the clinical efficacy and safety of total glucosides of peony combined with methotrexate in rheumatoid arthritis. Clin Rheumatol 2018;37:35\u201342.","journal-title":"Clin Rheumatol"},{"key":"4217_CR25","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.fitote.2012.04.012","volume":"83","author":"D Potdar","year":"2012","unstructured":"Potdar D, Hirwani RR, Dhulap S. Phytochemical and pharmacological applications of berberis aristata. Fitoterapia 2012;83:817\u2013830.","journal-title":"Fitoterapia"},{"key":"4217_CR26","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1002\/ptr.8077","volume":"38","author":"F Shakeri","year":"2024","unstructured":"Shakeri F, Kiani S, Rahimi G, et al. Anti-inflammatory, antioxidant, and immunomodulatory effects of Berberis vulgaris and its constituent berberine, experimental and clinical, a review. Phytother Res 2024;38:1882\u20131902.","journal-title":"Phytother Res"},{"key":"4217_CR27","doi-asserted-by":"publisher","first-page":"105667","DOI":"10.1016\/j.phrs.2021.105667","volume":"169","author":"D Huang","year":"2021","unstructured":"Huang D, Wu F, Zhang A, et al. Efficacy of berberine in treatment of rheumatoid arthritis: from multiple targets to therapeutic potential. Pharmacol Res 2021;169:105667.","journal-title":"Pharmacol Res"},{"key":"4217_CR28","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nprot.2007.173","volume":"2","author":"DD Brand","year":"2007","unstructured":"Brand DD, Latham KA, Rosloniec EF. Collagen-induced arthritis. Nat Protoc 2007;2:1269\u20131275.","journal-title":"Nat Protoc"},{"key":"4217_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11655-023-3753-6","volume":"30","author":"XR Liu","year":"2024","unstructured":"Liu XR, Li SF, Mei WY, Liu XD, Zhou RB. Isorhamnetin downregulates MMP2 and MMP9 to inhibit development of rheumatoid arthritis through SRC\/ERK\/CREB pathway. Chin J Integr Med 2024;30:299\u2013310.","journal-title":"Chin J Integr Med"},{"key":"4217_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.intimp.2014.08.024","volume":"23","author":"X Jia","year":"2014","unstructured":"Jia X, Chang Y, Sun X, et al. The role of prostaglandin E2 receptor signaling of dendritic cells in rheumatoid arthritis. Int Immunopharmacol 2014;23:163\u2013169.","journal-title":"Int Immunopharmacol"},{"key":"4217_CR31","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/art.30202","volume":"63","author":"Z Hu","year":"2011","unstructured":"Hu Z, Jiao Q, Ding J, et al. Berberine induces dendritic cell apoptosis and has therapeutic potential for rheumatoid arthritis. Arthritis Rheum 2011;63:949\u2013959.","journal-title":"Arthritis Rheum"},{"key":"4217_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10787-024-01612-x","volume":"33","author":"MM Nazir","year":"2025","unstructured":"Nazir MM, Farzeen I, Fasial S, et al. Berberine in rheumatoid arthritis: a comprehensive review and meta-analysis of its anti-inflammatory and immunomodulatory mechanisms in animal models. Inflammopharmacology 2025;33:215\u2013229.","journal-title":"Inflammopharmacology"},{"key":"4217_CR33","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s10495-019-01548-6","volume":"24","author":"P Dinesh","year":"2019","unstructured":"Dinesh P, Rasool M. Berberine mitigates IL-21\/IL-21R mediated autophagic influx in fibroblast-like synoviocytes and regulates Th17\/Treg imbalance in rheumatoid arthritis. Apoptosis 2019;24:644\u2013661.","journal-title":"Apoptosis"},{"key":"4217_CR34","doi-asserted-by":"publisher","first-page":"155064","DOI":"10.1016\/j.phymed.2023.155064","volume":"120","author":"S Chen","year":"2023","unstructured":"Chen S, Wang J, Wang J, et al. Wnt\/\u03b2-catenin signaling pathway promotes abnormal activation of fibroblast-like synoviocytes and angiogenesis in rheumatoid arthritis and the intervention of Er Miao San. Phytomedicine 2023;120:155064.","journal-title":"Phytomedicine"},{"key":"4217_CR35","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/ptr.7407","volume":"36","author":"SM Haftcheshmeh","year":"2022","unstructured":"Haftcheshmeh SM, Abedi M, Mashayekhi K, et al. Berberine as a natural modulator of inflammatory signaling pathways in the immune system: focus on NF-\u03b2 B, JAK\/STAT, and MAPK signaling pathways. Phytother Res 2022;36:1216\u20131230.","journal-title":"Phytother Res"},{"key":"4217_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 2010;233:233\u2013255.","journal-title":"Immunol Rev"},{"key":"4217_CR37","first-page":"594","volume":"27","author":"GD Jay","year":"2000","unstructured":"Jay GD, Britt DE, Cha CJ. Lubricin is a product of megakaryocyte stimulating factor gene expression by human synovial fibroblasts. J Rheumatol 2000;27:594\u2013600.","journal-title":"J Rheumatol"},{"key":"4217_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1365-2613.2009.00640.x","volume":"90","author":"EM Paleolog","year":"2009","unstructured":"Paleolog EM. The vasculature in rheumatoid arthritis: cause or consequence? Int J Exp Pathol 2009;90:249\u2013261.","journal-title":"Int J Exp Pathol"},{"key":"4217_CR39","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.coph.2004.04.003","volume":"4","author":"IB McInnes","year":"2004","unstructured":"McInnes IB, Gracie JA. Interleukin-15: a new cytokine target for the treatment of inflammatory diseases. Curr Opin Pharmacol 2004;4:392\u2013397.","journal-title":"Curr Opin Pharmacol"},{"key":"4217_CR40","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13075-017-1303-3","volume":"19","author":"MF Bustamante","year":"2017","unstructured":"Bustamante MF, Garcia-Carbonell R, Whisenant KD, et al. Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther 2017;19:110.","journal-title":"Arthritis Res Ther"},{"key":"4217_CR41","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1152\/ajpendo.90599.2008","volume":"296","author":"HW Jeong","year":"2009","unstructured":"Jeong HW, Hsu KC, Lee JW, et al. Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am J Physiol Endocrinol Metab 2009;296:955\u2013964.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4217_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1302\/2046-3758.122.BJR-2022-0269.R1","volume":"12","author":"Z Li","year":"2023","unstructured":"Li Z, Chen M, Wang Z, et al. Berberine inhibits RA-FLS cell proliferation and adhesion by regulating RAS\/MAPK\/FOXO\/HIF-1 signal pathway in the treatment of rheumatoid arthritis. Bone Joint Res 2023;12:91\u2013102.","journal-title":"Bone Joint Res"},{"key":"4217_CR43","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1258\/ebm.2011.010366","volume":"236","author":"X Wang","year":"2011","unstructured":"Wang X, Jiang S, Sun Q. Effects of berberine on human rheumatoid arthritis fibroblast-like synoviocytes. Exp Biol Med (Maywood) 2011;236:859\u2013866.","journal-title":"Exp Biol Med (Maywood)"},{"key":"4217_CR44","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ejpb.2020.02.007","volume":"149","author":"S Sujitha","year":"2020","unstructured":"Sujitha S, Dinesh P, Rasool M. Berberine encapsulated PEG-coated liposomes attenuate Wnt1\/\u03b2-catenin signaling in rheumatoid arthritis via miR-23a activation. Eur J Pharm Biopharm 2020;149:170\u2013191.","journal-title":"Eur J Pharm Biopharm"},{"key":"4217_CR45","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1002\/jps.23718","volume":"102","author":"J Ma","year":"2013","unstructured":"Ma J, Feng R, Tan X, et al. Excretion of berberine and its metabolites in oral administration in rats. J Pharm Sci 2013;102:4181\u20134192.","journal-title":"J Pharm Sci"},{"key":"4217_CR46","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1208\/s12249-011-9632-z","volume":"12","author":"W Chen","year":"2011","unstructured":"Chen W, Miao Y, Fan D, et al. Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats. AAPS Pharm Sci Tech 2011;12:705\u2013711.","journal-title":"AAPS Pharm Sci Tech"},{"key":"4217_CR47","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jpba.2007.03.022","volume":"44","author":"W Hua","year":"2007","unstructured":"Hua W, Ding L, Chen Y, et al. Determination of berberine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry. J Pharm Biomed Anal 2007;44:931\u2013937.","journal-title":"J Pharm Biomed Anal"},{"key":"4217_CR48","doi-asserted-by":"publisher","first-page":"12155","DOI":"10.1038\/srep12155","volume":"5","author":"R Feng","year":"2015","unstructured":"Feng R, Shou J, Zhao Z, et al. Transforming berberine into its intestine-absorbable form by the gut microbiota. Sci Rep 2015;5:12155.","journal-title":"Sci Rep"},{"key":"4217_CR49","doi-asserted-by":"publisher","first-page":"e77969","DOI":"10.1371\/journal.pone.0077969","volume":"8","author":"X Tan","year":"2013","unstructured":"Tan X, Ma J, Feng R, et al. Tissue distribution of berberine and its metabolites after oral administration in rats. PLoS One 2013;8:e77969.","journal-title":"PLoS One"},{"key":"4217_CR50","doi-asserted-by":"publisher","first-page":"12311","DOI":"10.1096\/fj.201900425RR","volume":"33","author":"M Yue","year":"2019","unstructured":"Yue M, Tao Y, Fang Y, et al. The gut microbiota modulator berberine ameliorates collagen-induced arthritis in rats by facilitating the generation of butyrate and adjusting the intestinal hypoxia and nitrate supply. FASEB J 2019;33:12311\u201312323.","journal-title":"FASEB J"},{"key":"4217_CR51","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.job.2022.11.003","volume":"65","author":"T Okuda","year":"2023","unstructured":"Okuda T, Jo R, Tsutsumi K, et al. An in vitro study of the effects of Phellodendron bark extract and berberine chloride on periodontal pathogenic bacteria in the oral microbiome. J Oral Biosci 2023;65:72\u201379.","journal-title":"J Oral Biosci"},{"key":"4217_CR52","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh A, De Vadder F, Kovatcheva-Datchary P, et al. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 2016;165:1332\u20131345.","journal-title":"Cell"},{"key":"4217_CR53","doi-asserted-by":"publisher","first-page":"eab","DOI":"10.1126\/sciadv.abm1511","volume":"8","author":"J He","year":"2022","unstructured":"He J, Chu Y, Li J, et al. Intestinal butyrate-metabolizing species contribute to autoantibody production and bone erosion in rheumatoid arthritis. Sci Adv 2022;8:eabm1511.","journal-title":"Sci Adv"},{"key":"4217_CR54","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41574-019-0205-7","volume":"15","author":"M Serino","year":"2019","unstructured":"Serino M. SCFAs\u2014the thin microbial metabolic line between good and bad. Nat Rev Endocrinol 2019;15:318\u2013319.","journal-title":"Nat Rev Endocrinol"},{"key":"4217_CR55","volume-title":"ACR Convergence","author":"J He","year":"2024","unstructured":"He J, Wang N, Li Y, et al. Efficacy, safety and mechanism of butyrate in the treatment of rheumatoid arthritis (RA). ACR Convergence 2024; Poster. NO:0514."},{"key":"4217_CR56","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.metabol.2017.02.003","volume":"70","author":"Y Wang","year":"2017","unstructured":"Wang Y, Shou J, Li X, et al. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism. Metabolism 2017;70:72\u201384.","journal-title":"Metabolism"},{"key":"4217_CR57","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3389\/fphar.2018.00214","volume":"9","author":"R Feng","year":"2018","unstructured":"Feng R, Zhao Z, Ma S, et al. Gut microbiota-regulated pharmacokinetics of berberine and active metabolites in Beagle dogs after oral administration. Front Pharmacol 2018;9:214.","journal-title":"Front Pharmacol"},{"key":"4217_CR58","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1038\/s41467-020-18414-8","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Gu Y, Ren H, et al. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nat Commun 2020;11:5015.","journal-title":"Nat Commun"},{"key":"4217_CR59","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-022-01027-6","volume":"7","author":"S Ma","year":"2022","unstructured":"Ma S, Tong Q, Lin Y, et al. Berberine treats atherosclerosis via a vitamine-like effect down-regulating choline-TMA-TMAO production pathway in gut microbiota. Signal Transduct Target Ther 2022;7:207.","journal-title":"Signal Transduct Target Ther"},{"key":"4217_CR60","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41392-020-00456-5","volume":"6","author":"Y Wang","year":"2021","unstructured":"Wang Y, Tong Q, Ma S, et al. Oral berberine improves brain Dopa\/dopamine levels to ameliorate Parkinson\u2019s disease by regulating gut microbiota. Signal Transduct Target Ther 2021;6:77.","journal-title":"Signal Transduct Target Ther"},{"key":"4217_CR61","doi-asserted-by":"publisher","first-page":"102776","DOI":"10.1016\/j.autrev.2021.102776","volume":"20","author":"FA Figus","year":"2021","unstructured":"Figus FA, Piga M, Azzolin I, et al. Rheumatoid arthritis: extra-articular manifestations and comorbidities. Autoimmun Rev 2021;20:102776.","journal-title":"Autoimmun Rev"},{"key":"4217_CR62","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1136\/ard-2022-222824","volume":"82","author":"L Hoisnard","year":"2023","unstructured":"Hoisnard L, Pina Vegas L, Dray-Spira R, et al. Risk of major adverse cardiovascular and venous thromboembolism events in patients with rheumatoid arthritis exposed to JAK inhibitors versus adalimumab: a nationwide cohort study. Ann Rheum Dis 2023;82:182\u2013188.","journal-title":"Ann Rheum Dis"},{"key":"4217_CR63","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/molecules27041351","volume":"27","author":"A Och","year":"2022","unstructured":"Och A, Och M, Nowak R, et al. Berberine, a herbal metabolite in the metabolic syndrome: the risk factors, course, and consequences of the disease. Molecules 2022;27:1351.","journal-title":"Molecules"},{"key":"4217_CR64","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1007\/s11596-024-2914-y","volume":"44","author":"C Chen","year":"2024","unstructured":"Chen C, Liu X, Deng B. Protective effects of berberine on nonalcoholic fatty liver disease in db\/db mice via AMPK\/SIRT1 pathway activation. Curr Med Sci 2024;44:902\u2013911.","journal-title":"Curr Med Sci"},{"key":"4217_CR65","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/nm1135","volume":"10","author":"W Kong","year":"2004","unstructured":"Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 2004;10:1344\u20131351.","journal-title":"Nat Med"},{"key":"4217_CR66","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/jcb.22667","volume":"111","author":"T Lee","year":"2010","unstructured":"Lee T, Pan C, Peng C, et al. Anti-atherogenic effect of berberine on LXRalpha-ABCA1-dependent cholesterol efflux in macrophages. J Cell Biochem 2010;111:104\u2013110.","journal-title":"J Cell Biochem"},{"key":"4217_CR67","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12902-017-0165-7","volume":"17","author":"L Zhao","year":"2017","unstructured":"Zhao L, Cang Z, Sun H, et al. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease. BMC Endocr Disord 2017;17:13.","journal-title":"BMC Endocr Disord"},{"key":"4217_CR68","doi-asserted-by":"publisher","first-page":"127824","DOI":"10.1016\/j.micres.2024.127824","volume":"287","author":"Z Wang","year":"2024","unstructured":"Wang Z, Shao Y, Wu F, et al. Berberine ameliorates vascular dysfunction by downregulating TMAO-endoplasmic reticulum stress pathway via gut microbiota in hypertension. Microbiol Res 2024;287:127824.","journal-title":"Microbiol Res"},{"key":"4217_CR69","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3109\/13880209.2012.655377","volume":"50","author":"T Lao-ong","year":"2012","unstructured":"Lao-ong T, Chatuphonprasert W, Nemoto N, et al. Alteration of hepatic glutathione peroxidase and superoxide dismutase expression in streptozotocin-induced diabetic mice by berberine. Pharm Biol 2012;50:1007\u20131012.","journal-title":"Pharm Biol"},{"key":"4217_CR70","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0049-3848(02)00133-0","volume":"106","author":"C Huang","year":"2002","unstructured":"Huang C, Chu Z, Wei S, et al. Effect of berberine on arachidonic acid metabolism in rabbit platelets and endothelial cells. Thromb Res 2002;106:223\u2013227.","journal-title":"Thromb Res"},{"key":"4217_CR71","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.pharep.2013.12.004","volume":"66","author":"M Gao","year":"2014","unstructured":"Gao M, Chen L, Yang L, et al. Berberine inhibits LPS-induced TF procoagulant activity and expression through NF-\u03ba B\/p65, Akt and MAPK pathway in THP-1 cells. Pharmacol Rep 2014;66:480\u2013484.","journal-title":"Pharmacol Rep"},{"key":"4217_CR72","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2174\/1389200221666200620203648","volume":"21","author":"B Sun","year":"2020","unstructured":"Sun B, Yang Y, He M, et al. Hepatoprotective role of berberine on doxorubicin induced hepatotoxicity-involvement of Cyp. Curr Drug Metab 2020;21:541\u2013547.","journal-title":"Curr Drug Metab"},{"key":"4217_CR73","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41584-022-00883-4","volume":"19","author":"V Di Martino","year":"2023","unstructured":"Di Martino V, Verhoeven DW, Verhoeven F, et al. Busting the myth of methotrexate chronic hepatotoxicity. Nat Rev Rheumatol 2023;19:96\u2013110.","journal-title":"Nat Rev Rheumatol"},{"key":"4217_CR74","doi-asserted-by":"publisher","first-page":"87412","DOI":"10.1007\/s11356-023-28279-1","volume":"30","author":"A Phogat","year":"2023","unstructured":"Phogat A, Singh J, Kumar V, et al. Berberine mitigates acetamiprid-induced hepatotoxicity and inflammation via regulating endogenous antioxidants and NF-\u03ba B\/TNF-\u03b1 signaling in rats. Environ Sci Pollut Res Int 2023;30:87412\u201387423.","journal-title":"Environ Sci Pollut Res Int"},{"key":"4217_CR75","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1007\/s12033-022-00651-5","volume":"65","author":"H Yuan","year":"2023","unstructured":"Yuan H, Wang B, Ye Z, et al. Berberine alleviates the damage, oxidative stress and mitochondrial dysfunction of PC12 cells induced by high glucose by activating the KEAP1\/Nrf2\/ARE pathway. Mol Biotechnol 2023;65:1632\u20131643.","journal-title":"Mol Biotechnol"},{"key":"4217_CR76","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3390\/ijms17071036","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Zhao Z, Yan Y, et al. Demethyleneberberine protects against hepatic fibrosis in mice by modulating NF-\u03baB signaling. Int J Mol Sci 2016;17.1036.","journal-title":"Int J Mol Sci"},{"key":"4217_CR77","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3109\/0886022X.2016.1165120","volume":"38","author":"M Adil","year":"2016","unstructured":"Adil M, Kandhare AD, Dalvi G, et al. Ameliorative effect of berberine against gentamicin-induced nephrotoxicity in rats via attenuation of oxidative stress, inflammation, apoptosis and mitochondrial dysfunction. Ren Fail 2016;38:996\u20131006.","journal-title":"Ren Fail"},{"key":"4217_CR78","doi-asserted-by":"publisher","first-page":"101612","DOI":"10.1016\/j.tice.2021.101612","volume":"73","author":"G Ibrahim Fouad","year":"2021","unstructured":"Ibrahim Fouad G, Ahmed KA. The protective impact of berberine against doxorubicin-induced nephrotoxicity in rats. Tissue Cell 2021;73:101612.","journal-title":"Tissue Cell"},{"key":"4217_CR79","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1111\/bph.14935","volume":"177","author":"X Qin","year":"2020","unstructured":"Qin X, Jiang M, Zhao Y, et al. Berberine protects against diabetic kidney disease via promoting PGC-1\u03b1-regulated mitochondrial energy homeostasis. Br J Pharmacol 2020;177:3646\u20133661.","journal-title":"Br J Pharmacol"},{"key":"4217_CR80","doi-asserted-by":"publisher","first-page":"120697","DOI":"10.1016\/j.lfs.2022.120697","volume":"306","author":"EHM Hassanein","year":"2022","unstructured":"Hassanein EHM, Ibrahim IM, Abd-Alhameed EK, et al. Protective effects of berberine on various kidney diseases: emphasis on the promising effects and the underlined molecular mechanisms. Life Sci 2022;306:120697.","journal-title":"Life Sci"},{"key":"4217_CR81","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejphar.2016.11.037","volume":"794","author":"Y Jin","year":"2017","unstructured":"Jin Y, Liu S, Ma Q, et al. Berberine enhances the AMPK activation and autophagy and mitigates high glucose-induced apoptosis of mouse podocytes. Eur J Pharmacol 2017;794:106\u2013114.","journal-title":"Eur J Pharmacol"},{"key":"4217_CR82","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.freeradbiomed.2019.06.019","volume":"141","author":"X Zhu","year":"2019","unstructured":"Zhu X, Bian H, Wang L, et al. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway. Free Radic Biol Med 2019;141:192\u2013204.","journal-title":"Free Radic Biol Med"},{"key":"4217_CR83","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.biopha.2018.10.088","volume":"109","author":"EHM Hassanein","year":"2019","unstructured":"Hassanein EHM, Shalkami A-GS, Khalaf MM, et al. The impact of Keap1\/Nrf2, P38MAPK\/NF-\u03ba B and Bax\/Bcl2\/caspase-3 signaling pathways in the protective effects of berberine against methotrexate-induced nephrotoxicity. Biomed Pharmacother 2019;109:47\u201356.","journal-title":"Biomed Pharmacother"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-025-4217-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-025-4217-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-025-4217-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T13:24:15Z","timestamp":1758720255000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-025-4217-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":83,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["4217"],"URL":"https:\/\/doi.org\/10.1007\/s11655-025-4217-y","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"type":"print","value":"1672-0415"},{"type":"electronic","value":"1993-0402"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"17 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest regarding the publication of this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}